what a bargain, page-11

bought a small parcel today at .52.Long term holder and have topped up a fair bit since FDA approval.

My question is where's Pete? One conference call, a patent announcement, a bit of a rubbish RBS presentation , a few snippets in AFR/Australian.

I thought he said HA trial stats Sept with possibility of earlier start in Australia. Reason given for delay until September was summer holidays over there. September is only 3 weeks away and no confirmation it's definitely happenning. Is he going to spring a delay on us? Is there a problem with getting funding? I would have thought he'd have the funding in place by now if it was starting in 3 weeks. Maybe it is all still...dare I say it... imminent.

He's going to lose some serious cred if he doesn't follow through on the things he discussed so confidently in the conference call.

I'm a big fan of their position of cash flow and HA phae 2 and 3 trials but am starting to agree a bit with the post of ... who owns close to a million shares. Can't blame the FDA for delays now.